These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1422319)

  • 41. Short-term effects on bone and mineral metabolism of 4-amino-1-hydroxybutylidene-1,1-diphosphonate (ABDP) in Paget's disease of bone.
    Pedrazzoni M; Palummeri E; Ciotti G; Davoli L; Pioli G; Girasole G; Passeri M
    Bone Miner; 1989 Nov; 7(3):301-7. PubMed ID: 2611449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human calcitonin treatment of Paget's disease of bone.
    Singer FR
    Clin Orthop Relat Res; 1977; (127):86-93. PubMed ID: 912995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gallium nitrate for advanced Paget disease of bone: effectiveness and dose-response analysis.
    Warrell RP; Bosco B; Weinerman S; Levine B; Lane J; Bockman RS
    Ann Intern Med; 1990 Dec; 113(11):847-51. PubMed ID: 2240900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ascorbic acid therapy for the relief of bone pain in Paget's disease.
    Basu TK; Smethurst M; Gillett MB; Donaldson D; Jordan SJ; Williams DC; Hicklin JA
    Acta Vitaminol Enzymol; 1978; 32(1-4):45-9. PubMed ID: 582875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long term effects of dichloromethylene diphosphonate in Paget's disease of bone.
    Delmas PD; Chapuy MC; Vignon E; Charhon S; Briancon D; Alexandre C; Edouard C; Meunier PJ
    J Clin Endocrinol Metab; 1982 Apr; 54(4):837-44. PubMed ID: 6460781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
    Walsh JP; Ward LC; Stewart GO; Will RK; Criddle RA; Prince RL; Stuckey BG; Dhaliwal SS; Bhagat CI; Retallack RW; Kent GN; Drury PJ; Vasikaran S; Gutteridge DH
    Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic strategy in Paget's disease of bone.
    Meunier PJ; Vignot E
    Bone; 1995 Nov; 17(5 Suppl):489S-491S. PubMed ID: 8573424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Galactosyl hydroxylysine in assessment of Paget's bone disease.
    Michalsky M; Stepan JJ; Wilczek H; Formankova J; Moro L
    Clin Chim Acta; 1995 Jan; 234(1-2):101-8. PubMed ID: 7758208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The treatment of Paget's bone disease with sodium ethidronate.
    Fromm GA; Schajowicz F; Casco C; Ghiringhelli G; Mautalen CA
    Am J Med Sci; 1979; 277(1):29-37. PubMed ID: 106728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity.
    Pons F; Alvarez L; Peris P; Guañabens N; Vidal-Sicart S; Monegal A; Pavía J; Ballesta AM; Muños-Gómez J; Herranz R
    Nucl Med Commun; 1999 Jun; 20(6):525-8. PubMed ID: 10451864
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glucagon in the treatment of Paget's disease of bone.
    Condon JR
    Br Med J; 1971 Dec; 4(5789):719-21. PubMed ID: 5129617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term therapy of Paget's disease of bone with EHDP.
    Siris ES; Canfield RE; Jacobs TP; Baquiran DC
    Arthritis Rheum; 1980 Oct; 23(10):1177-84. PubMed ID: 6775644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and tolerability of a new formulation of oral tiludronate (tablet) in the treatment of Paget's disease of bone.
    Reginster JY; Treves R; Renier JC; Amor B; Sany J; Ethgen D; Picot C; Franchimont P
    J Bone Miner Res; 1994 May; 9(5):615-9. PubMed ID: 8053389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate.
    Delmas PD; Chapuy MC; Meunier PJ
    Horm Metab Res; 1984 May; 16(5):258-61. PubMed ID: 6234216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
    Alvarez L; Peris P; Pons F; Guañabens N; Herranz R; Monegal A; Bedini JL; Deulofeu R; Martínez de Osaba MJ; Muñoz-Gómez J; Ballesta AM
    Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Salmon-calcitonin nasal spray in Paget's disease of bone: preliminary results in five patients.
    Reginster JY; Albert A; Franchimont P
    Calcif Tissue Int; 1985 Dec; 37(6):577-80. PubMed ID: 3937575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alendronate in the treatment of Paget's disease of bone.
    Khan SA; Vasikaran S; McCloskey EV; Benéton MN; Rogers S; Coulton L; Orgee J; Coombes G; Kanis JA
    Bone; 1997 Mar; 20(3):263-71. PubMed ID: 9071478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy.
    Patel S; Coupland CA; Stone MD; Hosking DJ
    Bone; 1995 Feb; 16(2):193-7. PubMed ID: 7756047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.
    Yates AJ; Percival RC; Gray RE; Atkins RM; Urwin GH; Hamdy NA; Preston CJ; Beneton MN; Russell RG; Kanis JA
    Lancet; 1985 Jun; 1(8444):1474-7. PubMed ID: 2861411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human calcitonin in the treatment of Paget's bone disease.
    Woodhouse NJ; Bordier P; Fisher M; Joplin GF; Reiner M; Kalu DN; Foster GV; MacIntyre I
    Lancet; 1971 Jun; 1(7710):1139-43. PubMed ID: 4102856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.